Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9926
SmartRent
SMRT
$257M
| $254K | ﹤0.01% |
146,670
+117,547
| +404% | +$223K |
|
|
CRESY
9927
Cresud
CRESY
$784M
| $254K | ﹤0.01% |
29,600
-11,551
| -28% | -$93.3K |
|
9928
PUT
MediaAlpha
MAX
$681M
| $254K | ﹤0.01% |
14,000
-65,100
| -82% | -$1.04M |
|
9929
Employers Holdings
EIG
$883M
| $253K | ﹤0.01% |
5,277
-434
| -8% | -$20.1K |
|
9930
Invesco Active US Real Estate Fund
PSR
$58.9M
| $253K | ﹤0.01% |
2,569
-16,325
| -86% | -$1.52M |
|
9931
Heron Therapeutics
HRTX
$62M
| $253K | ﹤0.01% |
127,117
-191,595
| -60% | -$457K |
|
9932
PUT
Hain Celestial
HAIN
$66.1M
| $253K | ﹤0.01% |
29,300
-19,300
| -40% | -$145K |
|
9933
CALL
Universal Insurance Holdings
UVE
$1.21B
| $253K | ﹤0.01% |
11,400
-19,200
| -63% | -$387K |
|
9934
Ecovyst
ECVT
$1.11B
| $252K | ﹤0.01% |
36,823
-86,846
| -70% | -$662K |
|
9935
ALPS Dynamic US Dividend Advantage ETF
RFDA
$82.8M
| $252K | ﹤0.01% |
4,568
-5,282
| -54% | -$283K |
|
9936
PUT
Sagimet Biosciences
SGMT
$656M
| $252K | ﹤0.01% |
+91,000
| New | +$280K |
|
|
MVO
9937
DELISTED
MV Oil Trust
MVO
| $252K | ﹤0.01% |
26,637
-7,546
| -22% | -$69.8K |
|
9938
CALL
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.4B
| $252K | ﹤0.01% |
+2,200
| New | +$242K |
|
9939
Rigel Pharmaceuticals
RIGL
$868M
| $252K | ﹤0.01% |
15,565
-1,897
| -11% | -$22.3K |
|
9940
C3.ai
AI
$1.64B
| $252K | ﹤0.01% |
10,390
-769,635
| -99% | -$19.6M |
|
9941
PUT
CONMED
CNMD
$1.5B
| $252K | ﹤0.01% |
3,500
+100
| +3% | +$7.06K |
|
9942
AMREP Corp
AXR
$123M
| $252K | ﹤0.01% |
+8,478
| New | +$196K |
|
9943
PUT
Rayonier Advanced Materials
RYAM
$582M
| $252K | ﹤0.01% |
29,400
-20,000
| -40% | -$139K |
|
|
IGMS
9944
CALL
DELISTED
IGM Biosciences
IGMS
| $251K | ﹤0.01% |
+15,200
| New | +$167K |
|
|
FORL
9945
DELISTED
Four Leaf Acquisition Corp
FORL
| $251K | ﹤0.01% |
23,043
-7,854
| -25% | -$86.3K |
|
9946
PUT
RPC Inc
RES
$1.42B
| $251K | ﹤0.01% |
39,500
-60,000
| -60% | -$378K |
|
9947
First Trust S&P 500 Diversified Free Cash Flow ETF
FCFY
$1.53M
| $251K | ﹤0.01% |
10,225
-5
| -0% | -$118 |
|
9948
Karyopharm Therapeutics
KPTI
$42.4M
| $251K | ﹤0.01% |
20,170
-9,395
| -32% | -$117K |
|
9949
PUT
Kimbell Royalty Partners
KRP
$1.5B
| $251K | ﹤0.01% |
15,600
-25,500
| -62% | -$411K |
|
9950
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.89B
| $251K | ﹤0.01% |
6,657
-51,560
| -89% | -$1.88M |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.